Table 2.
Cancer incidence rate by anatomic site in men in China, 2008–2012
| Cancer type | Rural areas | Urban areas | ||||
| Number of cases | Crude rate (95% CI) | Age-standardised rate (95% CI) | Number of cases | Crude rate (95% CI) | Age-standardised rate (95% CI) | |
| Lip, oral cavity and pharynx | 1517 | 6.3 (6.0 to 6.6) | 5.0 (4.8 to 5.3) | 18 962 | 14.2 (14.0 to 14.4) | 10.1 (10.0 to 10.2) |
| Oesophagus | 13 139 | 54.5 (53.6 to 55.4) | 43.5 (42.7 to 44.2) | 21 961 | 16.5 (16.2 to 16.7) | 11.1 (11.0 to 11.3) |
| Stomach | 18 515 | 76.8 (75.7 to 77.9) | 61.3 (60.4 to 62.2) | 45 179 | 33.9 (33.5 to 34.2) | 23.0 (22.8 to 23.2) |
| Small intestine | 190 | 0.8 (0.7 to 0.9) | 0.6 (0.5 to 0.7) | 2238 | 1.7 (1.6 to 1.7) | 1.2 (1.1 to 1.2) |
| Colon, rectum and anus | 5121 | 21.2 (20.7 to 21.8) | 17.1 (16.6 to 17.6) | 60 205 | 45.1 (44.8 to 45.5) | 30.7 (30.4 to 30.9) |
| Liver and biliary passages | 13 885 | 57.6 (56.7 to 58.6) | 45.8 (45.1 to 46.6) | 56 100 | 42.0 (41.7 to 42.4) | 29.0 (28.7 to 29.2) |
| Pancreas | 1802 | 7.5 (7.1 to 7.8) | 6.0 (5.8 to 6.3) | 12 593 | 9.4 (9.3 to 9.6) | 6.4 (6.3 to 6.5) |
| Larynx | 522 | 2.2 (2.0 to 2.4) | 1.7 (1.6 to 1.9) | 5679 | 4.3 (4.1 to 4.4) | 2.9 (2.8 to 3.0) |
| Lung | 15 740 | 65.3 (64.3 to 66.3) | 52.7 (51.9 to 53.5) | 104 382 | 78.2 (77.7 to 78.7) | 52.8 (52.5 to 53.1) |
| Bone | 612 | 2.5 (2.3 to 2.7) | 2.2 (2.0 to 2.4) | 2041 | 1.5 (1.5 to 1.6) | 1.2 (1.2 to 1.3) |
| Melanoma of skin | 119 | 0.5 (0.4 to 0.6) | 0.4 (0.3 to 0.5) | 922 | 0.7 (0.6 to 0.7) | 0.5 (0.5 to 0.5) |
| Skin, excluding melanoma | 542 | 2.2 (2.1 to 2.4) | 1.9 (1.7 to 2.0) | 5611 | 4.2 (4.1 to 4.3) | 2.9 (2.8 to 3.0) |
| Mesothelioma | 30 | 0.1 (0.1 to 0.2) | 0.1 (0.1 to 0.1) | 477 | 0.4 (0.3 to 0.4) | 0.2 (0.2 to 0.3) |
| Breast | 68 | 0.3 (0.2 to 0.4) | 0.2 (0.2 to 0.3) | 677 | 0.5 (0.5 to 0.5) | 0.4 (0.3 to 0.4) |
| Prostate | 1152 | 4.8 (4.5 to 5.1) | 4.0 (3.8 to 4.3) | 25 963 | 19.5 (19.2 to 19.7) | 13.0 (12.8 to 13.2) |
| Testis | 103 | 0.4 (0.3 to 0.5) | 0.4 (0.3 to 0.5) | 1176 | 0.9 (0.8 to 0.9) | 0.8 (0.8 to 0.9) |
| Other male genital organs | 184 | 0.8 (0.7 to 0.9) | 0.6 (0.5 to 0.7) | 1371 | 1.0 (1.0 to 1.1) | 0.7 (0.7 to 0.8) |
| Kidney | 535 | 2.2 (2.0 to 2.4) | 1.8 (1.7 to 2.0) | 11 201 | 8.4 (8.2 to 8.6) | 5.9 (5.8 to 6.0) |
| Bladder | 1610 | 6.7 (6.4 to 7.0) | 5.5 (5.2 to 5.7) | 16 013 | 12.0 (11.8 to 12.2) | 8.1 (8.0 to 8.2) |
| Other urinary organs | 121 | 0.5 (0.4 to 0.6) | 0.4 (0.3 to 0.5) | 2449 | 1.8 (1.8 to 1.9) | 1.2 (1.2 to 1.3) |
| Eye | 49 | 0.2 (0.2 to 0.3) | 0.2 (0.1 to 0.3) | 236 | 0.2 (0.2 to 0.2) | 0.2 (0.2 to 0.2) |
| Brain and nervous system | 1496 | 6.2 (5.9 to 6.5) | 5.3 (5.0 to 5.5) | 7454 | 5.6 (5.5 to 5.7) | 4.4 (4.3 to 4.5) |
| Thyroid | 293 | 1.2 (1.1 to 1.4) | 1.0 (0.9 to 1.1) | 7193 | 5.4 (5.3 to 5.5) | 4.2 (4.1 to 4.3) |
| Other endocrine organs | 130 | 0.5 (0.5 to 0.6) | 0.5 (0.4 to 0.5) | 1221 | 0.9 (0.9 to 1.0) | 0.8 (0.7 to 0.8) |
| Hodgkin lymphoma | 63 | 0.3 (0.2 to 0.3) | 0.2 (0.2 to 0.3) | 740 | 0.6 (0.5 to 0.6) | 0.5 (0.4 to 0.5) |
| Non-Hodgkin's lymphoma | 1266 | 5.3 (5.0 to 5.5) | 4.3 (4.1 to 4.6) | 10 025 | 7.5 (7.4 to 7.7) | 5.5 (5.4 to 5.6) |
| Multiple myeloma | 286 | 1.2 (1.1 to 1.3) | 0.9 (0.8 to 1.1) | 3096 | 2.3 (2.2 to 2.4) | 1.6 (1.5 to 1.6) |
| Lymphoid leukaemia | 1433 | 5.9 (5.6 to 6.3) | 5.4 (5.1 to 5.7) | 8751 | 6.6 (6.4 to 6.7) | 5.8 (5.6 to 5.9) |
| Other and unspecified | 1186 | 4.9 (4.6 to 5.2) | 4.1 (3.9 to 4.3) | 16 018 | 12.0 (11.8 to 12.2) | 8.5 (8.4 to 8.7) |
| All sites but skin | 81 167 | 336.7 (334.4 to 339.1) | 271.5 (269.6 to 273.4) | 444 323 | 333 (332 to 333.9) | 230.5 (229.8 to 231.2) |
| All sites | 81 709 | 339.0 (336.7 to 341.3) | 273.4 (271.5 to 275.2) | 449 934 | 337.2 (336.2 to 338.1) | 233.4 (232.7 to 234.1) |